Retinoblastoma-binding protein 2 induces epithelial-mesenchymal transition in esophageal squamous cancer cells

被引:3
作者
Qiao, Naian [1 ]
Wang, Shikun [2 ]
Hu, Likuan [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250012, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250012, Peoples R China
关键词
Epithelial cadherin; Epithelial-mesenchymal transition; Esophageal squamous cancer; Lung squamous cancer; Neural cadherin; Retinoblastoma-binding protein 2; HISTONE DEMETHYLASE RBP2; CADHERIN; METHYLATION; INVASION; GENE;
D O I
10.1007/s10529-015-1925-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives To investigate the effect of retinoblastoma-binding protein 2 (RBP2) on epithelial-mesenchymal transition (EMT) in esophageal squamous cancer cells and to compare the effect of RBP2 in lung squamous cancer cells and esophageal squamous cancer cells. Results When transfected with RBP2 siRNA, the migrated cells were 36.3 +/- A 6.03 by transwell migration assay, compared to 107 +/- A 6.7 cells in the control group. The mRNA level of epithelial cadherin (E-cadherin) was 1.54 +/- A 0.14 times higher than in the control group, and that of neural cadherin (N-cadherin) fell to 0.76 +/- A 0.03 times. The relative luciferase activity of E-cadherin promoter rose to 3.84 +/- A 0.23 times. Correspondingly, the expression of E-cadherin protein increased and that of N-cadherin protein decreased. When SK-MES-1 cells were transfected with RBP2 siRNA, their relative mRNA level of E-cadherin was 8.6 +/- A 0.37 times as high as that in control group, which was higher than that in Eca-109 cells. The E-cadherin protein was also greater in SK-MES-1 cells. Conclusion RBP2 could induce EMT in esophageal cancer cells and exert a greater effect on the expression of E-cadherin in lung squamous cells than in esophageal squamous cells.
引用
收藏
页码:2365 / 2370
页数:6
相关论文
共 15 条
  • [11] Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2
  • [12] Histone Demethylase RBP2 Promotes Lung Tumorigenesis and Cancer Metastasis
    Teng, Yu-Ching
    Lee, Cheng-Feng
    Li, Ying-Shiuan
    Chen, Yi-Ren
    Hsiao, Pei-Wen
    Chan, Meng-Yu
    Lin, Feng-Mao
    Huang, Hsien-Da
    Chen, Yen-Ting
    Jeng, Yung-Ming
    Hsu, Chih-Hung
    Yan, Qin
    Tsai, Ming-Daw
    Juan, Li-Jung
    [J]. CANCER RESEARCH, 2013, 73 (15) : 4711 - 4721
  • [13] Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer A Phase-II Study of The SWOG (S0414)
    Tomblyn, Michael B.
    Goldman, Bryan H.
    Thomas, Charles R., Jr.
    Benedetti, Jacqueline K.
    Lenz, Heinz-Josef
    Mehta, Vivek
    Beeker, Thaddeus
    Gold, Philip J.
    Abbruzzese, James L.
    Blanke, Charles D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) : 906 - 912
  • [14] RBP2 Induces Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer
    Wang, Shikun
    Wang, Yang
    Wu, Haijian
    Hu, Likuan
    [J]. PLOS ONE, 2013, 8 (12):
  • [15] SILENCING OF THE E-CADHERIN INVASION-SUPPRESSOR GENE BY CPG METHYLATION IN HUMAN CARCINOMAS
    YOSHIURA, K
    KANAI, Y
    OCHIAI, A
    SHIMOYAMA, Y
    SUGIMURA, T
    HIROHASHI, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) : 7416 - 7419